SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Aguirre Gamboa, Raul ^a   Gomez Rueda, Hugo ^a   Martínez Ledesma, Emmanuel ^a   Martínez Torteya, Antonio ^a   Chacolla Huaringa, Rafael ^a   Rodriguez Barrientos, Alberto ^a   Tamez Peña, José G ^a   Treviño, Victor ^a  

^a SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER PROGNOSIS; CANCER SURVIVAL; COMPUTER INTERFACE; COMPUTER PROGRAM; CONTROLLED STUDY; GENE EXPRESSION; GENETIC DATABASE; INTERMETHOD COMPARISON; LUNG CANCER; ONLINE SYSTEM; RISK ASSESSMENT; VALIDATION PROCESS;

BIOLOGICAL MARKERS; DATABASES, FACTUAL; GENE EXPRESSION PROFILING; HUMANS; INTERNET; NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84884180105     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074250     Document Type: Article

References (27)

1. Gyorffy B, Benke Z, Lanczky A, Balazs B, Szallasi Z, et al. (2012) RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data. Breast Cancer Res Treat 132: 1025-1034.
2. Venet D, Dumont JE, Detours V, (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 7: e1002240.
3. Kern SE, (2012) Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures. Cancer Res 72: 6097-6101.
4. Mizuno H, Kitada K, Nakai K, Sarai A, (2009) PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics 2: 18.
5. Ringner M, Fredlund E, Hakkinen J, Borg A, Staaf J, (2011) GOBO: gene expression-based outcome for breast cancer online. PLoS One 6: e17911.
6. Budczies J, Klauschen F, Sinn BV, Gyorffy B, Schmitt WD, et al. (2012) Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PLoS One 7: e51862.
7. Jezequel P, Frenel JS, Campion L, Guerin-Charbonnel C, Gouraud W, et al. (2013) bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses. Database (Oxford) 2013: bas060.
8. Elfilali A, Lair S, Verbeke C, La Rosa P, Radvanyi F, et al. (2006) ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis. Nucleic Acids Res 34: D613-616.
9. Corradi L, Mirisola V, Porro I, Torterolo L, Fato M, et al. (2009) Survival Online: a web-based service for the analysis of correlations between gene expression and clinical and follow-up data. BMC Bioinformatics 10Suppl 12: S10.
10. Schriml LM, Arze C, Nadendla S, Chang YW, Mazaitis M, et al. (2012) Disease Ontology: a backbone for disease semantic integration. Nucleic Acids Res 40: D940-946.
11. Collett D (1993) Modelling Survival Data in Medical Research: Chapman and Hall/CRC. 368 p.
12. Bovelstad HM, Borgan O, (2011) Assessment of evaluation criteria for survival prediction from genomic data. Biom J 53: 202-216.
13. Heagerty PJ, Zheng Y, (2005) Survival model predictive accuracy and ROC curves. Biometrics 61: 92-105.
14. Paik S, Shak S, Tang G, Kim C, Baker J, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826.
15. Kao KJ, Chang KM, Hsu HC, Huang AT, (2011) Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer 11: 143.
16. Subramanian J, Simon R, (2010) Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst 102: 464-474.
17. Boutros PC, Lau SK, Pintilie M, Liu N, Shepherd FA, et al. (2009) Prognostic gene signatures for non-small-cell lung cancer.
18. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, et al. (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356: 11-20.
19. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
20. Raponi M, Zhang Y, Yu J, Chen G, Lee G, et al. (2006) Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 66: 7466-7472.
21. Zhu CQ, Ding K, Strumpf D, Weir BA, Meyerson M, et al. (2010) Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncol 28: 4417-4424.
22. Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, et al. (2010) Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 5: e10312.
23. Shedden K, Taylor JMG, Enkemann SA, Tsao M-S, Yeatman TJ, et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nature Medicine 14: 822-827.
24. Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, et al. (2012) Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res 72: 100-111.
25. Network CGA, (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
26. Ivshina AV, George J, Senko O, Mow B, Putti TC, et al. (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66: 10292-10301.
27. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.